Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Prostate cancer (PCa) is a common malignant tumor with increasing incidence and high heterogeneity among males worldwide. In the era of big data and artificial intelligence, the paradigm of biomarker discovery is shifting from traditional experimental and small data-based identification toward big d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yuxin, Zhao, Xiaojun, Miao, Zhijun, Ling, Zhixin, Wei, Xuedong, Pu, Jinxian, Hou, Jianquan, Shen, Bairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060655/
https://www.ncbi.nlm.nih.gov/pubmed/32143723
http://dx.doi.org/10.1186/s12967-020-02281-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060655/
https://www.ncbi.nlm.nih.gov/pubmed/32143723
http://dx.doi.org/10.1186/s12967-020-02281-4

Ejemplares similares